Neurocrine Biosciences Inc
NBIXHealthcare|Drug Manufacturers - Specialty & Generic|USA
$177.19
-3.48 (-1.93%)
DCF (FCF)
$85.65
Tangible Book
$33.88
Graham Number
$70.17
Earnings Power
$56.09
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (688)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Delaet Ingrid | Chief Regulatory Officer | 2026-07-09 | SELL | 14,571 | $178.65 | $2603.1K |
| Lippoldt Darin | Chief Legal Officer | 2026-06-29 | SELL | 10,000 | $170.15 | $1701.5K |
| SHERWIN STEPHEN A | Director | 2026-06-05 | SELL | 25,000 | $165.32 | $4133K |
| Norwalk Leslie V | Director | 2026-06-04 | SELL | 1,250 | $168.06 | $210.1K |
| Cooke Julie | Chief Human Resources Officer | 2026-06-02 | SELL | 36,937 | $156.22 | $5770.3K |
| Onyia Jude | Chief Scientific Officer | 2026-06-01 | SELL | 11,000 | $160.25 | $1762.8K |
| Delaet Ingrid | Chief Regulatory Officer | 2026-05-29 | SELL | 2,261 | $156.71 | $354.3K |
| Onyia Jude | Chief Scientific Officer | 2026-05-27 | SELL | 11,000 | $155.53 | $1710.8K |
| Boyer David W. | Chief Corp. Affairs Officer | 2026-05-26 | SELL | 3,888 | $156.64 | $609K |
| GORMAN KEVIN CHARLES | Director | 2026-05-19 | SELL | 245,088 | $154.33 | $37824.4K |
| POPS RICHARD F | Director | 2026-05-15 | SELL | 15,000 | $157.65 | $2364.8K |
| Norwalk Leslie V | Director | 2026-05-12 | SELL | 3,810 | $155.01 | $590.6K |
| Gano Kyle | CEO | 2026-01-16 | SELL | 36,400 | $132.7 | $4830.3K |
| Norwalk Leslie V | Director | 2025-12-16 | SELL | 6,190 | $152.78 | $945.7K |
| Lippoldt Darin | Chief Legal Officer | 2025-12-08 | SELL | 4,376 | $159.65 | $698.6K |
| LYONS GARY A | Director | 2025-12-03 | SELL | 15,000 | $152.61 | $2289.2K |
| BENEVICH ERIC | Chief Commercial Officer | 2025-11-28 | SELL | 5,970 | $151.74 | $905.9K |
| MORROW GEORGE J | Director | 2025-11-25 | SELL | 15,000 | $143.37 | $2150.6K |
| RASTETTER WILLIAM H | Director | 2025-11-05 | SELL | 18,000 | $151.82 | $2732.8K |
| Gano Kyle | CEO | 2025-11-04 | SELL | 300 | $141.97 | $42.6K |
| GORMAN KEVIN CHARLES | Director | 2025-08-07 | SELL | 106,322 | $126.41 | $13440.2K |
| Delaet Ingrid | Chief Regulatory Officer | 2025-07-10 | SELL | 457 | $135 | $61.7K |
| Onyia Jude | Chief Scientific Officer | 2025-07-09 | SELL | 59,819 | $130.46 | $7804K |
| Onyia Jude | Chief Scientific Officer | 2025-07-02 | SELL | 20,362 | $130.13 | $2649.7K |
| GORMAN KEVIN CHARLES | Director | 2025-05-27 | SELL | 9,613 | $120.38 | $1157.2K |
| RASTETTER WILLIAM H | Director | 2025-05-05 | SELL | 30,000 | $110.2 | $3306K |
| ROBERTS EIRY | Chief Medical Officer | 2025-02-14 | SELL | 2,218 | $116.44 | $258.3K |
| Boyer David W. | Chief Corp. Affairs Officer | 2025-02-13 | SELL | 1,785 | $116.74 | $208.4K |
| GORMAN KEVIN CHARLES | Director | 2025-02-13 | SELL | 5,844 | $116.69 | $681.9K |
| BENEVICH ERIC | Chief Commercial Officer | 2025-02-13 | SELL | 2,154 | $116.73 | $251.4K |
| SHERWIN STEPHEN A | Director | 2025-02-13 | SELL | 13,831 | $116.69 | $1613.9K |
| Onyia Jude | Chief Scientific Officer | 2025-02-13 | SELL | 2,879 | $116.79 | $336.2K |
| Lippoldt Darin | Chief Legal Officer | 2025-02-13 | SELL | 2,184 | $116.75 | $255K |
| Gano Kyle | CEO | 2025-02-13 | SELL | 2,558 | $116.85 | $298.9K |
| Cooke Julie | Chief Human Resources Officer | 2025-02-13 | SELL | 1,551 | $116.78 | $181.1K |
| ABERNETHY MATT | CFO | 2025-02-13 | SELL | 2,558 | $116.86 | $298.9K |
| Delaet Ingrid | Chief Regulatory Officer | 2025-02-13 | SELL | 1,471 | $116.71 | $171.7K |
| Cooke Julie | Chief Human Resources Officer | 2025-02-10 | SELL | 700 | $118.28 | $82.8K |
| GORMAN KEVIN CHARLES | Director | 2025-02-10 | SELL | 2,274 | $118.37 | $269.2K |
| ROBERTS EIRY | Chief Medical Officer | 2025-02-10 | SELL | 980 | $118.22 | $115.9K |
| Lippoldt Darin | Chief Legal Officer | 2025-02-10 | SELL | 911 | $118.25 | $107.7K |
| ABERNETHY MATT | CFO | 2025-02-10 | SELL | 980 | $118.27 | $115.9K |
| Gano Kyle | CEO | 2025-02-10 | SELL | 980 | $118.39 | $116K |
| Boyer David W. | Chief Corp. Affairs Officer | 2025-02-10 | SELL | 700 | $118.31 | $82.8K |
| BENEVICH ERIC | Chief Commercial Officer | 2025-02-10 | SELL | 980 | $118.31 | $115.9K |
| Delaet Ingrid | Chief Regulatory Officer | 2025-02-03 | SELL | 1,045 | $150.81 | $157.6K |
| Boyer David W. | Chief Corp. Affairs Officer | 2025-01-31 | SELL | 1,104 | $152.94 | $168.8K |
| BENEVICH ERIC | Chief Commercial Officer | 2025-01-31 | SELL | 1,207 | $152.94 | $184.6K |
| ABERNETHY MATT | CFO | 2025-01-31 | SELL | 1,283 | $152.87 | $196.1K |
| GORMAN KEVIN CHARLES | Director | 2025-01-31 | SELL | 2,707 | $152.92 | $414K |
| ROBERTS EIRY | Chief Medical Officer | 2025-01-31 | SELL | 1,457 | $152.8 | $222.6K |
| Onyia Jude | Chief Scientific Officer | 2025-01-31 | SELL | 126 | $152.97 | $19.3K |
| Cooke Julie | Chief Human Resources Officer | 2025-01-31 | SELL | 1,740 | $152.89 | $266K |
| Lippoldt Darin | Chief Legal Officer | 2025-01-31 | SELL | 1,250 | $152.91 | $191.1K |
| Gano Kyle | CEO | 2025-01-31 | SELL | 1,541 | $152.87 | $235.6K |
| GORMAN KEVIN CHARLES | Director | 2025-01-27 | SELL | 146,105 | $149.46 | $21836.9K |
| Gano Kyle | CEO | 2025-01-15 | SELL | 65,000 | $141.5 | $9197.5K |
| Delaet Ingrid | Chief Regulatory Officer | 2024-12-17 | SELL | 1,091 | $135 | $147.3K |
| Onyia Jude | Chief Scientific Officer | 2024-11-29 | SELL | 2,331 | $126.29 | $294.4K |
| Boyer David W. | Chief Corp. Affairs Officer | 2024-10-03 | SELL | 1,295 | $113.66 | $147.2K |
| Boyer David W. | Chief Corp. Affairs Officer | 2024-09-13 | SELL | 3,461 | $121.88 | $421.8K |
| RASTETTER WILLIAM H | Director | 2024-08-15 | SELL | 14,250 | $146.69 | $2090.3K |
| LYONS GARY A | Director | 2024-08-13 | SELL | 11,570 | $150.43 | $1740.5K |
| ABERNETHY MATT | CFO | 2024-08-13 | SELL | 14,100 | $150.38 | $2120.4K |
| Delaet Ingrid | Chief Regulatory Officer | 2024-08-13 | SELL | 7,143 | $150.1 | $1072.2K |
| Delaet Ingrid | Chief Regulatory Officer | 2024-08-06 | SELL | 273 | $147.7 | $40.3K |
| Cooke Julie | Chief Human Resources Officer | 2024-08-01 | SELL | 12,632 | $153.26 | $1936K |
| Lippoldt Darin | Chief Legal Officer | 2024-08-01 | SELL | 2,996 | $154.01 | $461.4K |
| Delaet Ingrid | Chief Regulatory Officer | 2024-07-16 | SELL | 2,857 | $150.03 | $428.6K |
| LYONS GARY A | Director | 2024-07-16 | SELL | 930 | $150.03 | $139.5K |
| ABERNETHY MATT | CFO | 2024-07-16 | SELL | 900 | $150.04 | $135K |
| Lippoldt Darin | Chief Legal Officer | 2024-07-16 | SELL | 7,004 | $150 | $1050.6K |
| Cooke Julie | Chief Human Resources Officer | 2024-07-16 | SELL | 900 | $150.04 | $135K |
| Delaet Ingrid | Chief Regulatory Officer | 2024-07-01 | SELL | 272 | $138.11 | $37.6K |
| Cooke Julie | Chief Human Resources Officer | 2024-07-01 | SELL | 10,000 | $140.19 | $1401.9K |
| Delaet Ingrid | Chief Regulatory Officer | 2024-05-31 | SELL | 273 | $136.55 | $37.3K |
| SHERWIN STEPHEN A | Director | 2024-05-29 | SELL | 40,000 | $133.46 | $5338.4K |
| Norwalk Leslie V | Director | 2024-05-17 | SELL | 1,106 | $141.82 | $156.9K |
| Sharp Shalini | Director | 2024-05-17 | SELL | 1,106 | $141.9 | $156.9K |
| POPS RICHARD F | Director | 2024-05-17 | SELL | 2,100 | $141.84 | $297.9K |
| ABERNETHY MATT | CFO | 2024-05-15 | SELL | 30,000 | $137.95 | $4138.5K |
| LYONS GARY A | Director | 2024-05-14 | SELL | 12,500 | $135.63 | $1695.4K |
| Delaet Ingrid | Chief Regulatory Officer | 2024-05-06 | SELL | 273 | $140.55 | $38.4K |
| BENEVICH ERIC | Chief Commercial Officer | 2024-04-15 | SELL | 19,818 | $133.36 | $2642.9K |
| Delaet Ingrid | Chief Regulatory Officer | 2024-04-01 | SELL | 272 | $137.3 | $37.3K |
| Delaet Ingrid | Chief Regulatory Officer | 2024-03-21 | SELL | 5,000 | $145.06 | $725.3K |
| BENEVICH ERIC | Chief Commercial Officer | 2024-03-14 | SELL | 75,000 | $139.38 | $10453.5K |
| MORROW GEORGE J | Director | 2024-03-14 | SELL | 40,000 | $139.42 | $5576.8K |
| POPS RICHARD F | Director | 2024-03-13 | SELL | 23,200 | $140.33 | $3255.7K |
| Delaet Ingrid | Chief Regulatory Officer | 2024-03-13 | SELL | 3,000 | $140.14 | $420.4K |
| POPS RICHARD F | Director | 2024-03-11 | SELL | 1,800 | $140.04 | $252.1K |
| Delaet Ingrid | Chief Regulatory Officer | 2024-03-11 | SELL | 2,000 | $140.03 | $280.1K |
| Delaet Ingrid | Chief Regulatory Officer | 2024-02-29 | SELL | 6,817 | $135.34 | $922.6K |
| BENEVICH ERIC | Chief Commercial Officer | 2024-02-28 | SELL | 75,000 | $134.69 | $10101.8K |
| Norwalk Leslie V | Director | 2024-02-27 | SELL | 8,000 | $135.67 | $1085.4K |
| POPS RICHARD F | Director | 2024-02-20 | SELL | 15,000 | $132.47 | $1987.1K |
| BENEVICH ERIC | Chief Commercial Officer | 2024-02-13 | SELL | 1,098 | $133.01 | $146K |
| ABERNETHY MATT | CFO | 2024-02-13 | SELL | 1,352 | $132.85 | $179.6K |
| Gano Kyle | Chief Business Development Off | 2024-02-13 | SELL | 1,352 | $132.89 | $179.7K |
| Delaet Ingrid | Chief Regulatory Officer | 2024-02-13 | SELL | 716 | $133.03 | $95.2K |
| ROBERTS EIRY | Chief Medical Officer | 2024-02-13 | SELL | 1,114 | $132.96 | $148.1K |
| Onyia Jude | Chief Scientific Officer | 2024-02-13 | SELL | 1,432 | $132.94 | $190.4K |
| Cooke Julie | Chief Human Resources Officer | 2024-02-13 | SELL | 796 | $133.04 | $105.9K |
| Boyer David W. | Chief Corp. Affairs Officer | 2024-02-13 | SELL | 1,811 | $133.07 | $241K |
| Lippoldt Darin | Chief Legal Officer | 2024-02-13 | SELL | 1,098 | $132.99 | $146K |
| GORMAN KEVIN CHARLES | CEO | 2024-02-13 | SELL | 2,832 | $133.02 | $376.7K |
| BENEVICH ERIC | Chief Commercial Officer | 2024-02-08 | SELL | 2,260 | $138.68 | $313.4K |
| ABERNETHY MATT | CFO | 2024-02-08 | SELL | 2,260 | $138.73 | $313.5K |
| Boyer David W. | Chief Corp. Affairs Officer | 2024-02-08 | SELL | 1,784 | $137.09 | $244.6K |
| Cooke Julie | Chief Human Resources Officer | 2024-02-08 | SELL | 2,544 | $138.61 | $352.6K |
| ROBERTS EIRY | Chief Medical Officer | 2024-02-08 | SELL | 2,101 | $138.49 | $291K |
| Lippoldt Darin | Chief Legal Officer | 2024-02-08 | SELL | 1,952 | $138.47 | $270.3K |
| GORMAN KEVIN CHARLES | CEO | 2024-02-08 | SELL | 5,314 | $138.74 | $737.3K |
| Gano Kyle | Chief Business Development Off | 2024-02-08 | SELL | 2,580 | $139.16 | $359K |
| Delaet Ingrid | Chief Regulatory Officer | 2024-02-01 | SELL | 1,045 | $140.65 | $147K |
| ABERNETHY MATT | CFO | 2024-01-31 | SELL | 1,283 | $140.72 | $180.5K |
| Onyia Jude | Chief Scientific Officer | 2024-01-31 | SELL | 126 | $141.94 | $17.9K |
| Lippoldt Darin | Chief Legal Officer | 2024-01-31 | SELL | 1,250 | $140.65 | $175.8K |
| GORMAN KEVIN CHARLES | CEO | 2024-01-31 | SELL | 2,707 | $140.69 | $380.8K |
| Gano Kyle | Chief Business Development Off | 2024-01-31 | SELL | 1,541 | $140.7 | $216.8K |
| Cooke Julie | Chief Human Resources Officer | 2024-01-31 | SELL | 1,740 | $141.29 | $245.8K |
| Boyer David W. | Chief Corp. Affairs Officer | 2024-01-31 | SELL | 2,096 | $140.8 | $295.1K |
| BENEVICH ERIC | Chief Commercial Officer | 2024-01-31 | SELL | 1,207 | $140.78 | $169.9K |
| ROBERTS EIRY | Chief Medical Officer | 2024-01-31 | SELL | 1,457 | $140.79 | $205.1K |
| Lippoldt Darin | Chief Legal Officer | 2024-01-22 | SELL | 10,000 | $139.86 | $1398.6K |
| GORMAN KEVIN CHARLES | CEO | 2024-01-09 | SELL | 167,858 | $133.02 | $22328.5K |
| RASTETTER WILLIAM H | Director | 2024-01-02 | SELL | 11,044 | $131.47 | $1452K |
| Gano Kyle | Chief Business Development Off | 2024-01-02 | SELL | 75,000 | $131.47 | $9860.3K |
| LYONS GARY A | Director | 2023-12-22 | SELL | 10,000 | $130.04 | $1300.4K |
| Cooke Julie | Chief Human Resources Officer | 2023-12-22 | SELL | 24,000 | $128.66 | $3087.8K |
| ROBERTS EIRY | Chief Medical Officer | 2023-12-22 | SELL | 10,000 | $126.74 | $1267.4K |
| ROBERTS EIRY | Chief Medical Officer | 2023-12-12 | SELL | 13,925 | $120.3 | $1675.2K |
| ROBERTS EIRY | Chief Medical Officer | 2023-12-08 | SELL | 77,679 | $120.37 | $9350.2K |
| Lippoldt Darin | Chief Legal Officer | 2023-12-06 | SELL | 20,830 | $119.86 | $2496.7K |
| ROBERTS EIRY | Chief Medical Officer | 2023-12-06 | SELL | 8,396 | $120.03 | $1007.8K |
| LYONS GARY A | Director | 2023-12-01 | SELL | 5,000 | $116.77 | $583.9K |
| Onyia Jude | Chief Scientific Officer | 2023-11-29 | SELL | 2,331 | $113.57 | $264.7K |
| Lippoldt Darin | Chief Legal Officer | 2023-11-27 | SELL | 10,919 | $112.27 | $1225.9K |
| Boyer David W. | Chief Corp. Affairs Officer | 2023-10-02 | SELL | 1,437 | $112.68 | $161.9K |
| LYONS GARY A | Director | 2023-09-12 | SELL | 5,000 | $115.02 | $575.1K |
| LYONS GARY A | Director | 2023-09-01 | SELL | 5,000 | $110.06 | $550.3K |
| Cooke Julie | Chief Human Resources Officer | 2023-09-01 | SELL | 824 | $110.93 | $91.4K |
| Boyer David W. | Chief Corp. Affairs Officer | 2023-08-30 | SELL | 2,733 | $107.6 | $294.1K |
| Delaet Ingrid | Chief Regulatory Officer | 2023-08-28 | SELL | 1,431 | $107.52 | $153.9K |
| ROBERTS EIRY | Chief Medical Officer | 2023-08-21 | SELL | 3,198 | $107.38 | $343.4K |
| Onyia Jude | Chief Scientific Officer | 2023-08-21 | SELL | 3,198 | $107.37 | $343.4K |
| Lippoldt Darin | Chief Legal Officer | 2023-08-21 | SELL | 2,132 | $107.39 | $229K |
| GORMAN KEVIN CHARLES | CEO | 2023-08-21 | SELL | 9,328 | $107.4 | $1001.8K |
| Gano Kyle | Chief Business Development Off | 2023-08-21 | SELL | 2,132 | $107.41 | $229K |
| Delaet Ingrid | Chief Regulatory Officer | 2023-08-21 | SELL | 1,404 | $107.42 | $150.8K |
| Cooke Julie | Chief Human Resources Officer | 2023-08-21 | SELL | 2,132 | $107.41 | $229K |
| Boyer David W. | Chief Corp. Affairs Officer | 2023-08-21 | SELL | 1,600 | $107.41 | $171.9K |
| BENEVICH ERIC | Chief Commercial Officer | 2023-08-21 | SELL | 1,600 | $107.4 | $171.8K |
| ABERNETHY MATT | CFO | 2023-08-21 | SELL | 2,132 | $107.39 | $229K |
| RASTETTER WILLIAM H | Director | 2023-05-01 | SELL | 4,300 | $101.43 | $436.1K |
| Cooke Julie | Chief Human Resources Officer | 2023-05-01 | SELL | 11,397 | $103.89 | $1184K |
| Cooke Julie | Chief Human Resources Officer | 2023-04-25 | SELL | 100 | $103.82 | $10.4K |
| ROBERTS EIRY | Chief Medical Officer | 2023-04-24 | SELL | 14,400 | $103.48 | $1490.1K |
| RASTETTER WILLIAM H | Director | 2023-04-21 | SELL | 6,937 | $105.03 | $728.6K |
| Cooke Julie | Chief Human Resources Officer | 2023-02-08 | SELL | 17,079 | $102.76 | $1755K |
| ROBERTS EIRY | Chief Medical Officer | 2023-02-08 | SELL | 16,525 | $102.74 | $1697.8K |
| Lloyd-Smith Malcolm | Chief Integration Officer | 2023-02-08 | SELL | 15,318 | $102.64 | $1572.2K |
| Lippoldt Darin | Chief Legal Officer | 2023-02-08 | SELL | 16,275 | $102.71 | $1671.6K |
| GORMAN KEVIN CHARLES | CEO | 2023-02-08 | SELL | 29,044 | $102.9 | $2988.6K |
| Gano Kyle | Chief Business Development Off | 2023-02-08 | SELL | 17,004 | $102.79 | $1747.8K |
| Boyer David W. | Chief Corp. Affairs Officer | 2023-02-08 | SELL | 25,238 | $102.49 | $2586.6K |
| BENEVICH ERIC | Chief Commercial Officer | 2023-02-08 | SELL | 19,650 | $102.7 | $2018.1K |
| ABERNETHY MATT | CFO | 2023-02-08 | SELL | 28,588 | $102.61 | $2933.4K |
| Onyia Jude | Chief Scientific Officer | 2023-02-07 | SELL | 4,508 | $102.3 | $461.2K |
| BENEVICH ERIC | Chief Commercial Officer | 2023-01-31 | SELL | 1,207 | $109.95 | $132.7K |
| ABERNETHY MATT | CFO | 2023-01-31 | SELL | 1,283 | $109.98 | $141.1K |
| Cooke Julie | Chief Human Resources Officer | 2023-01-31 | SELL | 916 | $108.48 | $99.4K |
| Boyer David W. | Chief Corp. Affairs Officer | 2023-01-31 | SELL | 1,104 | $109.92 | $121.4K |
| ROBERTS EIRY | Chief Medical Officer | 2023-01-31 | SELL | 1,457 | $109.99 | $160.3K |
| Onyia Jude | Chief Scientific Officer | 2023-01-31 | SELL | 126 | $108.48 | $13.7K |
| Lloyd-Smith Malcolm | Chief Integration Officer | 2023-01-31 | SELL | 1,666 | $110.02 | $183.3K |
| Lippoldt Darin | Chief Legal Officer | 2023-01-31 | SELL | 1,250 | $109.97 | $137.5K |
| GORMAN KEVIN CHARLES | CEO | 2023-01-31 | SELL | 2,707 | $110.08 | $298K |
| Gano Kyle | Chief Business Development Off | 2023-01-31 | SELL | 1,541 | $109.98 | $169.5K |
| BENEVICH ERIC | Chief Commercial Officer | 2023-01-06 | SELL | 400 | $125 | $50K |
| SHERWIN STEPHEN A | Director | 2023-01-03 | SELL | 30,000 | $118.86 | $3565.8K |
| POPS RICHARD F | Director | 2023-01-03 | SELL | 15,000 | $119.2 | $1788K |
| BENEVICH ERIC | Chief Commercial Officer | 2022-11-30 | SELL | 50,000 | $125.9 | $6295K |
| Onyia Jude | Chief Scientific Officer | 2022-11-29 | SELL | 2,331 | $121.9 | $284.1K |
| BENEVICH ERIC | Chief Commercial Officer | 2022-11-10 | SELL | 24,693 | $125.33 | $3094.8K |
| Lippoldt Darin | Chief Legal Officer | 2022-11-08 | SELL | 5,082 | $125.04 | $635.5K |
| Cooke Julie | Chief Human Resources Officer | 2022-11-08 | SELL | 5,592 | $124.99 | $698.9K |
| Cooke Julie | Chief Human Resources Officer | 2022-11-03 | SELL | 8,408 | $125 | $1051K |
| BENEVICH ERIC | Chief Commercial Officer | 2022-11-03 | SELL | 9,368 | $125.02 | $1171.2K |
| Lippoldt Darin | Chief Legal Officer | 2022-11-03 | SELL | 4,518 | $125.02 | $564.8K |
| Lippoldt Darin | Chief Legal Officer | 2022-11-02 | SELL | 10,400 | $120.28 | $1250.9K |
| Boyer David W. | Chief Corp. Affairs Officer | 2022-10-31 | SELL | 1,295 | $114.12 | $147.8K |
| LYONS GARY A | Director | 2022-10-31 | SELL | 15,000 | $114.76 | $1721.4K |
| Lippoldt Darin | Chief Legal Officer | 2022-10-27 | SELL | 10,000 | $115.03 | $1150.3K |
| BENEVICH ERIC | Chief Commercial Officer | 2022-10-17 | SELL | 4,960 | $110.82 | $549.7K |
| Lippoldt Darin | Chief Legal Officer | 2022-10-04 | SELL | 10,000 | $111.04 | $1110.4K |
| LYONS GARY A | Director | 2022-10-04 | SELL | 5,000 | $110.54 | $552.7K |
| Boyer David W. | Chief Corp. Affairs Officer | 2022-10-03 | SELL | 1,437 | $106.59 | $153.2K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2022-08-12 | SELL | 21,533 | $105.95 | $2281.4K |
| Cooke Julie | Chief Human Resources Officer | 2022-08-05 | SELL | 1,816 | $100 | $181.6K |
| Cooke Julie | Chief Human Resources Officer | 2022-06-27 | SELL | 754 | $100 | $75.4K |
| POPS RICHARD F | Director | 2022-05-09 | SELL | 15,000 | $76.3 | $1144.5K |
| LYONS GARY A | Director | 2022-04-25 | SELL | 15,000 | $92.76 | $1391.4K |
| RASTETTER WILLIAM H | Director | 2022-04-01 | SELL | 10,728 | $94.93 | $1018.4K |
| Lippoldt Darin | Chief Legal Officer | 2022-03-22 | SELL | 8,755 | $95.05 | $832.2K |
| Boyer David W. | Chief Corp. Affairs Officer | 2022-02-08 | SELL | 940 | $79.99 | $75.2K |
| ROBERTS EIRY | Chief Medical Officer | 2022-02-08 | SELL | 3,724 | $80.45 | $299.6K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2022-02-08 | SELL | 3,382 | $80.48 | $272.2K |
| Lippoldt Darin | Chief Legal Officer | 2022-02-08 | SELL | 4,079 | $80.45 | $328.2K |
| GORMAN KEVIN CHARLES | CEO | 2022-02-08 | SELL | 10,984 | $80.54 | $884.7K |
| Gano Kyle | Chief Business Development Off | 2022-02-08 | SELL | 6,880 | $80.61 | $554.6K |
| Cooke Julie | Chief Human Resources Officer | 2022-02-08 | SELL | 2,858 | $80.38 | $229.7K |
| BENEVICH ERIC | Chief Commercial Officer | 2022-02-08 | SELL | 5,099 | $80.57 | $410.8K |
| ABERNETHY MATT | CFO | 2022-02-08 | SELL | 4,290 | $80.53 | $345.5K |
| SHERWIN STEPHEN A | Director | 2022-01-24 | SELL | 15,000 | $74.43 | $1116.5K |
| ROBERTS EIRY | Chief Medical Officer | 2022-01-10 | SELL | 2,632 | $74.5 | $196.1K |
| Gano Kyle | Chief Business Development Off | 2022-01-05 | SELL | 28,266 | $85.5 | $2416.7K |
| ABERNETHY MATT | CFO | 2021-12-01 | SELL | 1,645 | $82.59 | $135.9K |
| LYONS GARY A | Director | 2021-10-07 | SELL | 5,000 | $105.06 | $525.3K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2021-10-07 | SELL | 8,000 | $104.81 | $838.5K |
| Cooke Julie | Chief Human Resources Officer | 2021-10-04 | SELL | 987 | $101.73 | $100.4K |
| BENEVICH ERIC | Chief Commercial Officer | 2021-08-16 | SELL | 5,628 | $89.62 | $504.4K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2021-07-27 | SELL | 16,709 | $93.8 | $1567.3K |
| LYONS GARY A | Director | 2021-06-10 | SELL | 10,000 | $100.27 | $1002.7K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2021-02-10 | SELL | 1,700 | $119.96 | $203.9K |
| Lippoldt Darin | Chief Legal Officer | 2021-02-09 | SELL | 40,206 | $116.19 | $4671.5K |
| Gano Kyle | Chief Business Development Off | 2021-02-08 | SELL | 6,370 | $115.65 | $736.7K |
| ABERNETHY MATT | CFO | 2021-02-08 | SELL | 2,910 | $116.82 | $339.9K |
| Bozigian Haig P. | Chief Development Officer | 2021-02-08 | SELL | 4,546 | $116.33 | $528.8K |
| BENEVICH ERIC | Chief Commercial Officer | 2021-02-08 | SELL | 5,079 | $116.38 | $591.1K |
| Cooke Julie | Chief Human Resources Officer | 2021-02-08 | SELL | 1,943 | $115.84 | $225.1K |
| ROBERTS EIRY | Chief Medical Officer | 2021-02-08 | SELL | 2,363 | $116.78 | $276K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2021-02-08 | SELL | 4,126 | $116.26 | $479.7K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2021-02-08 | SELL | 3,313 | $116.16 | $384.8K |
| GORMAN KEVIN CHARLES | CEO | 2021-02-08 | SELL | 12,888 | $116.26 | $1498.4K |
| BENEVICH ERIC | Chief Commercial Officer | 2021-01-26 | SELL | 5,477 | $120.02 | $657.3K |
| LYONS GARY A | Director | 2021-01-26 | SELL | 2,000 | $120.02 | $240K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2021-01-26 | SELL | 18,670 | $119.97 | $2239.8K |
| ROBERTS EIRY | Chief Medical Officer | 2021-01-08 | SELL | 2,632 | $111.06 | $292.3K |
| GORMAN KEVIN CHARLES | CEO | 2021-01-08 | SELL | 308,250 | $110.22 | $33975.3K |
| ABERNETHY MATT | CFO | 2020-12-01 | SELL | 1,645 | $94.66 | $155.7K |
| ABERNETHY MATT | CFO | 2020-11-12 | SELL | 2,257 | $90.74 | $204.8K |
| BENEVICH ERIC | Chief Commercial Officer | 2020-11-12 | SELL | 2,257 | $90.71 | $204.7K |
| ROBERTS EIRY | Chief Medical Officer | 2020-11-12 | SELL | 2,257 | $90.74 | $204.8K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2020-11-12 | SELL | 2,257 | $90.73 | $204.8K |
| Lippoldt Darin | Chief Legal Officer | 2020-11-12 | SELL | 2,257 | $90.72 | $204.8K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2020-11-12 | SELL | 2,257 | $90.73 | $204.8K |
| GORMAN KEVIN CHARLES | CEO | 2020-11-12 | SELL | 3,390 | $90.78 | $307.7K |
| Gano Kyle | Chief Business Development Off | 2020-11-12 | SELL | 2,257 | $90.73 | $204.8K |
| Cooke Julie | Chief Human Resources Officer | 2020-11-12 | SELL | 2,257 | $90.73 | $204.8K |
| Bozigian Haig P. | Chief Development Officer | 2020-11-12 | SELL | 2,257 | $90.74 | $204.8K |
| BENEVICH ERIC | Chief Commercial Officer | 2020-11-02 | SELL | 20,595 | $96.53 | $1988K |
| Cooke Julie | Chief Human Resources Officer | 2020-10-02 | SELL | 987 | $95.26 | $94K |
| GORMAN KEVIN CHARLES | CEO | 2020-08-05 | SELL | 3,390 | $118.91 | $403.1K |
| Gano Kyle | Chief Business Development Off | 2020-08-05 | SELL | 2,257 | $118.87 | $268.3K |
| Cooke Julie | Chief Human Resources Officer | 2020-08-05 | SELL | 2,257 | $118.91 | $268.4K |
| Bozigian Haig P. | Chief Development Officer | 2020-08-05 | SELL | 2,257 | $118.89 | $268.3K |
| BENEVICH ERIC | Chief Commercial Officer | 2020-08-05 | SELL | 2,257 | $118.85 | $268.2K |
| ABERNETHY MATT | CFO | 2020-08-05 | SELL | 2,257 | $118.9 | $268.4K |
| ROBERTS EIRY | Chief Medical Officer | 2020-08-05 | SELL | 2,257 | $118.84 | $268.2K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2020-08-05 | SELL | 2,257 | $118.86 | $268.3K |
| Lippoldt Darin | Chief Legal Officer | 2020-08-05 | SELL | 2,257 | $118.87 | $268.3K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2020-08-05 | SELL | 2,257 | $118.83 | $268.2K |
| Lippoldt Darin | Chief Legal Officer | 2020-07-09 | SELL | 1,657 | $136.02 | $225.4K |
| Lippoldt Darin | Chief Legal Officer | 2020-06-23 | SELL | 5,000 | $130 | $650K |
| ROBERTS EIRY | Chief Medical Officer | 2020-06-23 | SELL | 5,000 | $130 | $650K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2020-05-19 | SELL | 52,749 | $125.31 | $6610K |
| Lippoldt Darin | Chief Legal Officer | 2020-05-18 | SELL | 5,000 | $120 | $600K |
| Bozigian Haig P. | Chief Development Officer | 2020-05-12 | SELL | 61,555 | $114.94 | $7075.1K |
| ABERNETHY MATT | CFO | 2020-05-07 | SELL | 15,000 | $110.21 | $1653.2K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2020-05-07 | SELL | 8,682 | $105.44 | $915.4K |
| SHERWIN STEPHEN A | Director | 2020-04-28 | SELL | 17,687 | $99.39 | $1757.9K |
| ABERNETHY MATT | CFO | 2020-04-28 | SELL | 1,741 | $102.49 | $178.4K |
| ROBERTS EIRY | Chief Medical Officer | 2020-04-24 | SELL | 1,934 | $99.47 | $192.4K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2020-04-24 | SELL | 1,934 | $99.45 | $192.3K |
| Lippoldt Darin | Chief Legal Officer | 2020-04-24 | SELL | 1,934 | $99.49 | $192.4K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2020-04-24 | SELL | 1,934 | $99.41 | $192.3K |
| GORMAN KEVIN CHARLES | CEO | 2020-04-24 | SELL | 2,906 | $99.45 | $289K |
| Gano Kyle | Chief Business Development Off | 2020-04-24 | SELL | 1,934 | $99.47 | $192.4K |
| Cooke Julie | Chief Human Resources Officer | 2020-04-24 | SELL | 1,934 | $99.46 | $192.4K |
| Bozigian Haig P. | Chief Development Officer | 2020-04-24 | SELL | 1,934 | $99.46 | $192.4K |
| BENEVICH ERIC | Chief Commercial Officer | 2020-04-24 | SELL | 1,934 | $99.45 | $192.3K |
| ABERNETHY MATT | CFO | 2020-04-24 | SELL | 1,934 | $99.52 | $192.5K |
| BENEVICH ERIC | Chief Commercial Officer | 2020-04-15 | SELL | 8,632 | $94.65 | $817K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2020-02-10 | SELL | 29,984 | $104.52 | $3133.9K |
| ROBERTS EIRY | Chief Medical Officer | 2020-02-07 | SELL | 1,623 | $103.31 | $167.7K |
| Lippoldt Darin | Chief Legal Officer | 2020-02-07 | SELL | 1,522 | $103.32 | $157.3K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2020-02-07 | SELL | 1,218 | $103.31 | $125.8K |
| GORMAN KEVIN CHARLES | CEO | 2020-02-07 | SELL | 3,248 | $103.35 | $335.7K |
| Gano Kyle | Chief Business Development Off | 2020-02-07 | SELL | 1,623 | $103.33 | $167.7K |
| Cooke Julie | Chief Human Resources Officer | 2020-02-07 | SELL | 913 | $103.26 | $94.3K |
| Bozigian Haig P. | Chief Development Officer | 2020-02-07 | SELL | 1,623 | $103.33 | $167.7K |
| BENEVICH ERIC | Chief Commercial Officer | 2020-02-07 | SELL | 2,030 | $103.32 | $209.7K |
| ABERNETHY MATT | CFO | 2020-02-07 | SELL | 2,030 | $103.35 | $209.8K |
| Gano Kyle | Chief Business Development Off | 2020-02-06 | SELL | 4,690 | $102.7 | $481.7K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2020-02-06 | SELL | 2,421 | $102.58 | $248.3K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2020-02-06 | SELL | 3,438 | $102.38 | $352K |
| Lippoldt Darin | Chief Legal Officer | 2020-02-06 | SELL | 2,948 | $102.36 | $301.8K |
| GORMAN KEVIN CHARLES | CEO | 2020-02-06 | SELL | 9,792 | $102.41 | $1002.8K |
| Bozigian Haig P. | Chief Development Officer | 2020-02-06 | SELL | 3,441 | $102.43 | $352.5K |
| BENEVICH ERIC | Chief Commercial Officer | 2020-02-06 | SELL | 3,349 | $102.38 | $342.9K |
| Cooke Julie | Chief Human Resources Officer | 2020-02-05 | SELL | 605 | $103.17 | $62.4K |
| ROBERTS EIRY | Chief Medical Officer | 2020-01-08 | SELL | 2,632 | $111.11 | $292.4K |
| ABERNETHY MATT | CFO | 2019-12-02 | SELL | 1,645 | $116.33 | $191.4K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2019-11-18 | SELL | 5,000 | $115.98 | $579.9K |
| LYONS GARY A | Director | 2019-11-08 | SELL | 5,000 | $110 | $550K |
| Lippoldt Darin | Chief Legal Officer | 2019-11-08 | SELL | 10,000 | $110.01 | $1100.1K |
| LYONS GARY A | Director | 2019-11-01 | SELL | 5,000 | $100.22 | $501.1K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2019-11-01 | SELL | 10,188 | $100.34 | $1022.3K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2019-10-14 | SELL | 9,956 | $90.85 | $904.5K |
| Cooke Julie | Chief Human Resources Officer | 2019-10-02 | SELL | 987 | $88.56 | $87.4K |
| Lippoldt Darin | Chief Legal Officer | 2019-09-03 | SELL | 6,736 | $100 | $673.6K |
| Lippoldt Darin | Chief Legal Officer | 2019-08-27 | SELL | 3,264 | $100.05 | $326.6K |
| GORMAN KEVIN CHARLES | CEO | 2019-08-08 | SELL | 80,000 | $95.31 | $7624.8K |
| LYONS GARY A | Director | 2019-07-30 | SELL | 10,000 | $92.07 | $920.7K |
| Lippoldt Darin | Chief Legal Officer | 2019-07-30 | SELL | 15,831 | $92.13 | $1458.5K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2019-07-30 | SELL | 60,000 | $92.92 | $5575.2K |
| Bozigian Haig P. | Chief Development Officer | 2019-07-30 | SELL | 44,356 | $92.77 | $4114.9K |
| Bozigian Haig P. | Chief Development Officer | 2019-07-15 | SELL | 30,680 | $87.5 | $2684.5K |
| BENEVICH ERIC | Chief Commercial Officer | 2019-07-15 | SELL | 5,835 | $87.44 | $510.2K |
| Bozigian Haig P. | Chief Development Officer | 2019-07-11 | SELL | 7,220 | $87.63 | $632.7K |
| Bozigian Haig P. | Chief Development Officer | 2019-06-18 | SELL | 2,100 | $87.82 | $184.4K |
| Bozigian Haig P. | Chief Development Officer | 2019-06-13 | SELL | 17,268 | $82.62 | $1426.7K |
| Bozigian Haig P. | Chief Development Officer | 2019-06-03 | SELL | 3,435 | $85.51 | $293.7K |
| Bozigian Haig P. | Chief Development Officer | 2019-05-31 | SELL | 19,297 | $85.02 | $1640.6K |
| Bozigian Haig P. | Chief Development Officer | 2019-05-24 | SELL | 17,486 | $80.03 | $1399.4K |
| Bozigian Haig P. | Chief Development Officer | 2019-05-22 | SELL | 1,300 | $80.03 | $104K |
| Bozigian Haig P. | Chief Development Officer | 2019-05-16 | SELL | 66,667 | $80.13 | $5342K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2019-05-13 | SELL | 1,657 | $75.44 | $125K |
| Bozigian Haig P. | Chief Development Officer | 2019-05-13 | SELL | 34,547 | $75.51 | $2608.6K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2019-02-06 | SELL | 920 | $83.58 | $76.9K |
| Lippoldt Darin | Chief Legal Officer | 2019-02-06 | SELL | 791 | $83.52 | $66.1K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2019-02-06 | SELL | 531 | $84.03 | $44.6K |
| GORMAN KEVIN CHARLES | CEO | 2019-02-06 | SELL | 4,096 | $84.23 | $345K |
| Gano Kyle | Chief Business Development Off | 2019-02-06 | SELL | 762 | $83.56 | $63.7K |
| Bozigian Haig P. | Chief Development Officer | 2019-02-06 | SELL | 920 | $83.54 | $76.9K |
| BENEVICH ERIC | Chief Commercial Officer | 2019-02-06 | SELL | 920 | $83.57 | $76.9K |
| Bozigian Haig P. | Chief Development Officer | 2019-02-05 | SELL | 2,725 | $88.12 | $240.1K |
| BENEVICH ERIC | Chief Commercial Officer | 2019-02-05 | SELL | 1,357 | $88.01 | $119.4K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2019-02-05 | SELL | 1,272 | $88.14 | $112.1K |
| Lippoldt Darin | Chief Legal Officer | 2019-02-05 | SELL | 1,225 | $88.09 | $107.9K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2019-02-05 | SELL | 2,445 | $88.14 | $215.5K |
| GORMAN KEVIN CHARLES | CEO | 2019-02-05 | SELL | 7,614 | $88.16 | $671.3K |
| Gano Kyle | Chief Business Development Off | 2019-02-05 | SELL | 3,809 | $88.12 | $335.6K |
| ROBERTS EIRY | Chief Medical Officer | 2019-01-08 | SELL | 1,857 | $84.09 | $156.2K |
| ABERNETHY MATT | CFO | 2018-12-03 | SELL | 1,178 | $90 | $106K |
| POPS RICHARD F | Director | 2018-11-26 | SELL | 4,124 | $91.37 | $376.8K |
| POPS RICHARD F | Director | 2018-11-12 | SELL | 4,123 | $103.3 | $425.9K |
| Bozigian Haig P. | Chief Development Officer | 2018-11-08 | SELL | 36,295 | $110 | $3992.5K |
| Bozigian Haig P. | Chief Development Officer | 2018-11-07 | SELL | 38,819 | $110.13 | $4275.1K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2018-11-07 | SELL | 9,000 | $110.01 | $990.1K |
| LYONS GARY A | Director | 2018-11-02 | SELL | 15,000 | $114.41 | $1716.2K |
| POPS RICHARD F | Director | 2018-10-29 | SELL | 5,500 | $107.13 | $589.2K |
| Gano Kyle | Chief Business Development Off | 2018-08-01 | SELL | 28,266 | $115 | $3250.6K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2018-08-01 | SELL | 23,022 | $110 | $2532.4K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2018-06-20 | SELL | 23,000 | $105 | $2415K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2018-06-14 | SELL | 86,963 | $99.48 | $8651.1K |
| LYONS GARY A | Director | 2018-06-13 | SELL | 15,000 | $99.24 | $1488.6K |
| SHERWIN STEPHEN A | Director | 2018-06-11 | SELL | 10,000 | $98.44 | $984.4K |
| BENEVICH ERIC | Chief Commercial Officer | 2018-06-01 | SELL | 12,350 | $97.34 | $1202.1K |
| Nevinny Corinne H | Director | 2018-05-07 | SELL | 5,000 | $83.13 | $415.7K |
| GORMAN KEVIN CHARLES | CEO | 2018-05-01 | SELL | 126,832 | $80.75 | $10241.7K |
| Lippoldt Darin | Chief Legal Officer | 2018-03-05 | SELL | 1,979 | $88.47 | $175.1K |
| Gano Kyle | Chief Business Development Off | 2018-03-05 | SELL | 23,650 | $90 | $2128.5K |
| Bozigian Haig P. | Chief Development Officer | 2018-03-05 | SELL | 75,873 | $90 | $6828.6K |
| LYONS GARY A | Director | 2018-02-15 | SELL | 5,000 | $84.67 | $423.4K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2018-02-12 | SELL | 86,368 | $78.32 | $6764.3K |
| GORMAN KEVIN CHARLES | CEO | 2018-02-06 | SELL | 105,983 | $80.25 | $8505.1K |
| BENEVICH ERIC | Chief Commercial Officer | 2018-02-05 | SELL | 820 | $83.14 | $68.2K |
| Gano Kyle | Chief Business Development Off | 2018-02-05 | SELL | 2,046 | $83.05 | $169.9K |
| OBrien Christopher Flint | Former Chief Medical Officer | 2018-02-05 | SELL | 2,613 | $83.18 | $217.3K |
| LYONS GARY A | Director | 2018-02-05 | SELL | 5,000 | $83.08 | $415.4K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2018-02-05 | SELL | 960 | $83.19 | $79.9K |
| Lippoldt Darin | Chief Legal Officer | 2018-02-05 | SELL | 2,737 | $83.12 | $227.5K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2018-02-05 | SELL | 2,046 | $83.09 | $170K |
| Bozigian Haig P. | Chief Development Officer | 2018-02-05 | SELL | 2,262 | $83.1 | $188K |
| RASTETTER WILLIAM H | Director | 2018-01-24 | SELL | 9,500 | $90 | $855K |
| OBrien Christopher Flint | Chief Medical Officer | 2018-01-16 | SELL | 1,750 | $79.14 | $138.5K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2018-01-16 | SELL | 1,625 | $79.12 | $128.6K |
| GORMAN KEVIN CHARLES | CEO | 2018-01-16 | SELL | 3,750 | $78.89 | $295.8K |
| Gano Kyle | Chief Business Development Off | 2018-01-16 | SELL | 1,625 | $79.05 | $128.5K |
| Bozigian Haig P. | Chief Development Officer | 2018-01-16 | SELL | 1,625 | $79.12 | $128.6K |
| Lippoldt Darin | Chief Legal Officer | 2018-01-03 | SELL | 1,979 | $79.36 | $157.1K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2018-01-02 | SELL | 18,084 | $77.52 | $1401.9K |
| Lippoldt Darin | Chief Legal Officer | 2017-12-28 | SELL | 15,237 | $75 | $1142.8K |
| Lippoldt Darin | Chief Legal Officer | 2017-12-08 | SELL | 2,955 | $75 | $221.6K |
| Lippoldt Darin | Chief Legal Officer | 2017-12-04 | SELL | 6,279 | $75.04 | $471.2K |
| LYONS GARY A | Director | 2017-12-01 | SELL | 10,000 | $72.92 | $729.2K |
| Lippoldt Darin | Chief Legal Officer | 2017-11-15 | SELL | 9,900 | $73.05 | $723.2K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2017-11-08 | SELL | 30,000 | $74.58 | $2237.4K |
| OBrien Christopher Flint | Chief Medical Officer | 2017-11-02 | SELL | 52,817 | $69.71 | $3681.9K |
| Gano Kyle | Chief Business Development Off | 2017-11-02 | SELL | 24,818 | $71.05 | $1763.3K |
| OBrien Christopher Flint | Chief Medical Officer | 2017-10-02 | SELL | 6,925 | $61.04 | $422.7K |
| Gano Kyle | Chief Business Development Off | 2017-09-06 | SELL | 20,393 | $60 | $1223.6K |
| Lippoldt Darin | Chief Legal Officer | 2017-09-06 | SELL | 100 | $60 | $6K |
| Gano Kyle | Chief Business Development Off | 2017-09-06 | SELL | 4,607 | $60 | $276.4K |
| Bozigian Haig P. | Chief Development Officer | 2017-09-06 | SELL | 26,250 | $60 | $1575K |
| OBrien Christopher Flint | Chief Medical Officer | 2017-09-05 | SELL | 52,817 | $57.5 | $3037K |
| Lippoldt Darin | Chief Legal Officer | 2017-08-09 | SELL | 5,000 | $55 | $275K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2017-08-09 | SELL | 15,354 | $55 | $844.5K |
| Bozigian Haig P. | Chief Development Officer | 2017-08-04 | SELL | 22,500 | $50 | $1125K |
| OBrien Christopher Flint | Chief Medical Officer | 2017-07-27 | SELL | 8,734 | $50 | $436.7K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2017-05-23 | SELL | 10,000 | $53.39 | $533.9K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2017-05-19 | SELL | 9,960 | $53.63 | $534.2K |
| OBrien Christopher Flint | Chief Medical Officer | 2017-05-18 | SELL | 105,634 | $53.32 | $5632.4K |
| Lippoldt Darin | Chief Legal Officer | 2017-05-18 | SELL | 10,000 | $53.27 | $532.7K |
| Nevinny Corinne H | Director | 2017-05-05 | SELL | 5,000 | $53.98 | $269.9K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2017-05-02 | SELL | 10,000 | $55 | $550K |
| GORMAN KEVIN CHARLES | CEO | 2017-05-02 | SELL | 21,739 | $53.23 | $1157.2K |
| Gano Kyle | Chief Business Development Off | 2017-05-01 | SELL | 15,000 | $54 | $810K |
| OBrien Christopher Flint | Chief Medical Officer | 2017-04-12 | SELL | 13,065 | $50.42 | $658.7K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2017-04-12 | SELL | 13,065 | $50.42 | $658.7K |
| Lippoldt Darin | Chief Legal Officer | 2017-04-12 | SELL | 13,065 | $50.42 | $658.7K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2017-04-12 | SELL | 13,065 | $50.42 | $658.7K |
| GORMAN KEVIN CHARLES | CEO | 2017-04-12 | SELL | 19,596 | $50.42 | $988K |
| Gano Kyle | Chief Business Development Off | 2017-04-12 | SELL | 13,065 | $50.42 | $658.7K |
| Bozigian Haig P. | Chief Development Officer | 2017-04-12 | SELL | 13,065 | $50.42 | $658.7K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2017-02-07 | SELL | 843 | $43.35 | $36.5K |
| BENEVICH ERIC | Chief Commercial Officer | 2017-02-07 | SELL | 953 | $43.32 | $41.3K |
| Lippoldt Darin | Chief Legal Officer | 2017-02-07 | SELL | 953 | $43.34 | $41.3K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2017-02-06 | SELL | 727 | $43.13 | $31.4K |
| Bozigian Haig P. | Chief Development Officer | 2017-02-06 | SELL | 963 | $43.14 | $41.5K |
| Gano Kyle | Chief Business Development Off | 2017-02-06 | SELL | 727 | $43.15 | $31.4K |
| OBrien Christopher Flint | Chief Medical Officer | 2017-02-06 | SELL | 1,206 | $43.17 | $52.1K |
| Coughlin Timothy P | CFO | 2017-02-06 | SELL | 963 | $43.14 | $41.5K |
| GORMAN KEVIN CHARLES | CEO | 2017-02-06 | SELL | 3,010 | $43.18 | $130K |
| Bozigian Haig P. | Chief Development Officer | 2017-02-03 | SELL | 1,375 | $42.57 | $58.5K |
| Coughlin Timothy P | CFO | 2017-02-03 | SELL | 1,500 | $42.55 | $63.8K |
| Gano Kyle | Chief Business Development Off | 2017-02-03 | SELL | 1,375 | $42.57 | $58.5K |
| GORMAN KEVIN CHARLES | CEO | 2017-02-03 | SELL | 3,125 | $42.55 | $133K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2017-02-03 | SELL | 1,375 | $42.56 | $58.5K |
| OBrien Christopher Flint | Chief Medical Officer | 2017-02-03 | SELL | 1,500 | $42.5 | $63.8K |
| RASTETTER WILLIAM H | Director | 2017-02-01 | SELL | 10,750 | $42.28 | $454.5K |
| Bozigian Haig P. | Chief Development Officer | 2017-01-17 | SELL | 1,625 | $40.63 | $66K |
| Coughlin Timothy P | CFO | 2017-01-17 | SELL | 1,750 | $40.65 | $71.1K |
| Gano Kyle | Chief Business Development Off | 2017-01-17 | SELL | 1,625 | $40.65 | $66.1K |
| GORMAN KEVIN CHARLES | CEO | 2017-01-17 | SELL | 3,750 | $40.65 | $152.4K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2017-01-17 | SELL | 1,625 | $40.63 | $66K |
| OBrien Christopher Flint | Chief Medical Officer | 2017-01-17 | SELL | 1,750 | $40.66 | $71.2K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2017-01-10 | SELL | 1,625 | $43.39 | $70.5K |
| GORMAN KEVIN CHARLES | CEO | 2017-01-10 | SELL | 3,750 | $43.28 | $162.3K |
| Gano Kyle | Chief Business Development Off | 2017-01-10 | SELL | 1,250 | $43.37 | $54.2K |
| Coughlin Timothy P | CFO | 2017-01-10 | SELL | 1,750 | $43.37 | $75.9K |
| Bozigian Haig P. | Chief Development Officer | 2017-01-10 | SELL | 1,625 | $43.37 | $70.5K |
| OBrien Christopher Flint | Chief Medical Officer | 2017-01-10 | SELL | 1,750 | $43.35 | $75.9K |
| OBrien Christopher Flint | Chief Medical Officer | 2016-11-15 | SELL | 25,000 | $52.84 | $1321K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2016-09-01 | SELL | 9,000 | $50 | $450K |
| OBrien Christopher Flint | Chief Medical Officer | 2016-08-15 | SELL | 12,500 | $48.73 | $609.1K |
| Nevinny Corinne H | Director | 2016-08-08 | SELL | 5,000 | $48.54 | $242.7K |
| Lloyd-Smith Malcolm | Chief Regulatory Officer | 2016-05-31 | SELL | 9,000 | $50 | $450K |
| OBrien Christopher Flint | Chief Medical Officer | 2016-05-31 | SELL | 12,500 | $50 | $625K |
| POPS RICHARD F | Director | 2016-05-25 | SELL | 15,000 | $46.72 | $700.8K |
| OBrien Christopher Flint | Chief Medical Officer | 2016-05-16 | SELL | 25,000 | $45 | $1125K |
| Gano Kyle | Chief Business Development Off | 2016-04-11 | SELL | 41,770 | $44.02 | $1838.7K |
| OBrien Christopher Flint | Chief Medical Officer | 2016-04-06 | SELL | 25,000 | $45 | $1125K |
| OBrien Christopher Flint | Chief Medical Officer | 2016-02-03 | SELL | 1,500 | $38.01 | $57K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2016-02-03 | SELL | 1,375 | $37.98 | $52.2K |
| GORMAN KEVIN CHARLES | President and CEO | 2016-02-03 | SELL | 3,125 | $38.04 | $118.9K |
| Gano Kyle | Chief Business Development Off | 2016-02-03 | SELL | 1,375 | $37.98 | $52.2K |
| Coughlin Timothy P | CFO | 2016-02-03 | SELL | 1,500 | $38.06 | $57.1K |
| Bozigian Haig P. | Chief Development Officer | 2016-02-03 | SELL | 1,375 | $38.13 | $52.4K |
| OBrien Christopher Flint | Chief Medical Officer | 2016-01-19 | SELL | 1,750 | $46.77 | $81.8K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2016-01-19 | SELL | 1,625 | $46.76 | $76K |
| GORMAN KEVIN CHARLES | President and CEO | 2016-01-19 | SELL | 3,750 | $46.7 | $175.1K |
| Gano Kyle | Chief Business Development Off | 2016-01-19 | SELL | 1,625 | $46.84 | $76.1K |
| Coughlin Timothy P | CFO | 2016-01-19 | SELL | 1,750 | $46.69 | $81.7K |
| Bozigian Haig P. | Chief Development Officer | 2016-01-19 | SELL | 1,625 | $46.77 | $76K |
| OBrien Christopher Flint | Chief Medical Officer | 2016-01-11 | SELL | 1,750 | $44.25 | $77.4K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2016-01-11 | SELL | 1,625 | $44.21 | $71.8K |
| GORMAN KEVIN CHARLES | President and CEO | 2016-01-11 | SELL | 3,750 | $44.17 | $165.6K |
| Gano Kyle | Chief Business Development Off | 2016-01-11 | SELL | 1,250 | $44.23 | $55.3K |
| Coughlin Timothy P | CFO | 2016-01-11 | SELL | 1,750 | $44.25 | $77.4K |
| Bozigian Haig P. | Chief Development Officer | 2016-01-11 | SELL | 1,625 | $44.25 | $71.9K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2015-11-27 | SELL | 10,000 | $57.5 | $575K |
| Lippoldt Darin | Chief Legal Officer | 2015-11-09 | SELL | 23,761 | $52.92 | $1257.4K |
| OBrien Christopher Flint | Chief Medical Officer | 2015-10-16 | SELL | 25,000 | $47.78 | $1194.5K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2015-10-16 | SELL | 25,000 | $47.77 | $1194.3K |
| GORMAN KEVIN CHARLES | President and CEO | 2015-10-16 | SELL | 33,500 | $47.77 | $1600.3K |
| Gano Kyle | Chief Business Development Off | 2015-10-16 | SELL | 25,000 | $47.77 | $1194.3K |
| Coughlin Timothy P | CFO | 2015-10-16 | SELL | 25,000 | $47.78 | $1194.5K |
| Bozigian Haig P. | Chief Development Officer | 2015-10-16 | SELL | 25,000 | $47.78 | $1194.5K |
| LYONS GARY A | Director | 2015-09-18 | SELL | 15,000 | $54.89 | $823.4K |
| OBrien Christopher Flint | Chief Medical Officer | 2015-07-20 | SELL | 11,250 | $55 | $618.8K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2015-07-20 | SELL | 19,646 | $55 | $1080.5K |
| Coughlin Timothy P | CFO | 2015-07-20 | SELL | 20,000 | $55 | $1100K |
| OBrien Christopher Flint | Chief Medical Officer | 2015-07-13 | SELL | 10,000 | $50 | $500K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2015-07-13 | SELL | 10,000 | $50 | $500K |
| Coughlin Timothy P | CFO | 2015-07-13 | SELL | 20,000 | $50 | $1000K |
| MITCHELL W THOMAS | Director | 2015-06-23 | SELL | 15,000 | $49.35 | $740.3K |
| OBrien Christopher Flint | Chief Medical Officer | 2015-06-08 | SELL | 10,000 | $45 | $450K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2015-06-08 | SELL | 10,000 | $45 | $450K |
| Coughlin Timothy P | CFO | 2015-06-08 | SELL | 60,000 | $45.08 | $2704.8K |
| Gano Kyle | See Remarks | 2015-06-01 | SELL | 38,230 | $42.19 | $1612.9K |
| OBrien Christopher Flint | Chief Medical Officer | 2015-06-01 | SELL | 10,000 | $42.2 | $422K |
| GORMAN KEVIN CHARLES | President and CEO | 2015-03-24 | SELL | 40,000 | $41.53 | $1661.2K |
| LYONS GARY A | Director | 2015-03-24 | SELL | 30,000 | $41.53 | $1245.9K |
| Coughlin Timothy P | CFO | 2015-03-20 | SELL | 40,000 | $44.49 | $1779.6K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2015-02-23 | SELL | 20,000 | $40 | $800K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2015-02-10 | SELL | 20,000 | $35 | $700K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2015-01-16 | SELL | 1,625 | $30.77 | $50K |
| Bozigian Haig P. | Chief Development Officer | 2015-01-16 | SELL | 1,625 | $30.79 | $50K |
| Gano Kyle | Chief Business Dev Officer | 2015-01-16 | SELL | 1,625 | $30.8 | $50.1K |
| GORMAN KEVIN CHARLES | President and CEO | 2015-01-16 | SELL | 3,750 | $30.79 | $115.5K |
| Coughlin Timothy P | CFO | 2015-01-16 | SELL | 1,750 | $30.81 | $53.9K |
| OBrien Christopher Flint | Chief Medical Officer | 2015-01-16 | SELL | 1,750 | $30.79 | $53.9K |
| Gano Kyle | Chief Business Dev Officer | 2015-01-13 | SELL | 25,000 | $30 | $750K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2015-01-13 | SELL | 20,000 | $30 | $600K |
| MITCHELL W THOMAS | Director | 2015-01-13 | SELL | 45,000 | $30.07 | $1353.2K |
| Coughlin Timothy P | CFO | 2015-01-12 | SELL | 1,750 | $28.37 | $49.6K |
| Bozigian Haig P. | Chief Development Officer | 2015-01-12 | SELL | 1,625 | $28.45 | $46.2K |
| OBrien Christopher Flint | Chief Medical Officer | 2015-01-12 | SELL | 1,750 | $28.41 | $49.7K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2015-01-12 | SELL | 1,625 | $28.38 | $46.1K |
| Gano Kyle | Chief Business Dev Officer | 2015-01-12 | SELL | 1,250 | $28.41 | $35.5K |
| GORMAN KEVIN CHARLES | President and CEO | 2015-01-12 | SELL | 3,750 | $28.43 | $106.6K |
| Coughlin Timothy P | CFO | 2015-01-08 | SELL | 10,000 | $27.25 | $272.5K |
| OBrien Christopher Flint | Chief Medical Officer | 2015-01-08 | SELL | 55,000 | $27.22 | $1497.1K |
| Bozigian Haig P. | Chief Development Officer | 2015-01-08 | SELL | 30,000 | $27.24 | $817.2K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2015-01-08 | SELL | 30,000 | $27.35 | $820.5K |
| GORMAN KEVIN CHARLES | President and CEO | 2015-01-08 | SELL | 25,000 | $27.39 | $684.8K |
| Bozigian Haig P. | Chief Development Officer | 2015-01-05 | SELL | 2,500 | $22.76 | $56.9K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2015-01-05 | SELL | 2,500 | $22.76 | $56.9K |
| MITCHELL W THOMAS | Director | 2015-01-02 | SELL | 8,000 | $22.79 | $182.3K |
| OBrien Christopher Flint | CHIEF MEDICAL OFFICER | 2014-12-19 | SELL | 20,000 | $24.02 | $480.4K |
| GORMAN KEVIN CHARLES | PRESIDENT AND CEO | 2014-12-19 | SELL | 70,000 | $23.41 | $1638.7K |
| Coughlin Timothy P | CFO | 2014-12-19 | SELL | 30,000 | $23.46 | $703.8K |
| Bozigian Haig P. | Chief Development Officer | 2014-12-17 | SELL | 15,002 | $22.51 | $337.7K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2014-12-17 | SELL | 14,706 | $22.5 | $330.9K |
| Gano Kyle | Chief Business Dev Officer | 2014-12-17 | SELL | 4,957 | $22.5 | $111.5K |
| Bozigian Haig P. | Chief Development Officer | 2014-12-15 | SELL | 12,498 | $22.34 | $279.2K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2014-12-15 | SELL | 12,794 | $22.35 | $285.9K |
| Gano Kyle | Chief Business Dev Officer | 2014-12-12 | SELL | 4,043 | $22.5 | $91K |
| OBrien Christopher Flint | Chief Medical Officer | 2014-12-11 | SELL | 40,000 | $21.82 | $872.8K |
| MITCHELL W THOMAS | Director | 2014-12-10 | SELL | 7,000 | $21.9 | $153.3K |
| Coughlin Timothy P | CFO | 2014-12-10 | SELL | 20,000 | $21.48 | $429.6K |
| Coughlin Timothy P | CFO | 2014-11-28 | SELL | 10,000 | $20.14 | $201.4K |
| OBrien Christopher Flint | Chief Medical Officer | 2014-11-24 | SELL | 5,463 | $19.53 | $106.7K |
| OBrien Christopher Flint | Chief Medical Officer | 2014-11-17 | SELL | 11,300 | $19.51 | $220.5K |
| OBrien Christopher Flint | Chief Medical Officer | 2014-11-13 | SELL | 3,237 | $19.5 | $63.1K |
| OBrien Christopher Flint | Chief Medical Officer | 2014-11-10 | SELL | 20,000 | $18.62 | $372.4K |
| Coughlin Timothy P | CFO | 2014-10-31 | SELL | 10,000 | $19 | $190K |
| Coughlin Timothy P | CFO | 2014-10-30 | SELL | 20,000 | $18.31 | $366.2K |
| MITCHELL W THOMAS | Director | 2014-10-01 | SELL | 1,275 | $15.5 | $19.8K |
| LYONS GARY A | Director | 2014-09-15 | SELL | 20,000 | $15.66 | $313.2K |
| Grigoriadis Dimitri E. | CHIEF RESEARCH OFFICER | 2014-01-17 | SELL | 25,000 | $20 | $500K |
| Bozigian Haig P. | CHIEF DEVELOPMENT OFFICER | 2014-01-17 | SELL | 25,000 | $20 | $500K |
| GORMAN KEVIN CHARLES | President and CEO | 2014-01-10 | SELL | 3,750 | $18.57 | $69.6K |
| Coughlin Timothy P | CFO | 2014-01-10 | SELL | 1,750 | $18.56 | $32.5K |
| OBrien Christopher Flint | Chief Medical Officer | 2014-01-10 | SELL | 6,750 | $18.88 | $127.4K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2014-01-10 | SELL | 1,625 | $18.56 | $30.2K |
| Bozigian Haig P. | Chief Development Officer | 2014-01-10 | SELL | 1,625 | $18.58 | $30.2K |
| Gano Kyle | Chief Business Dev Officer | 2014-01-10 | SELL | 1,250 | $18.57 | $23.2K |
| GORMAN KEVIN CHARLES | President and CEO | 2014-01-07 | SELL | 108,000 | $16.76 | $1810.1K |
| Coughlin Timothy P | CFO | 2014-01-07 | SELL | 70,000 | $16.75 | $1172.5K |
| OBrien Christopher Flint | Chief Medical Officer | 2014-01-07 | SELL | 5,000 | $17.5 | $87.5K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2014-01-07 | SELL | 25,000 | $17.5 | $437.5K |
| Bozigian Haig P. | Chief Development Officer | 2014-01-07 | SELL | 25,000 | $17.5 | $437.5K |
| Gano Kyle | Chief Business Dev Officer | 2013-09-04 | SELL | 2,400 | $15.61 | $37.5K |
| OBrien Christopher Flint | Chief Medical Officer | 2013-09-03 | SELL | 5,000 | $16 | $80K |
| Coughlin Timothy P | CFO | 2013-08-21 | SELL | 19,035 | $15.05 | $286.5K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2013-08-21 | SELL | 13,600 | $15.05 | $204.7K |
| Bozigian Haig P. | Chief Development Officer | 2013-08-21 | SELL | 13,999 | $15.04 | $210.5K |
| MITCHELL W THOMAS | Director | 2013-08-06 | SELL | 1,531 | $14.7 | $22.5K |
| OBrien Christopher Flint | Chief Medical Officer | 2013-08-05 | SELL | 5,000 | $15 | $75K |
| Coughlin Timothy P | CFO | 2013-08-05 | SELL | 10,965 | $14.99 | $164.4K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2013-08-05 | SELL | 11,400 | $15.01 | $171.1K |
| Bozigian Haig P. | Chief Development Officer | 2013-08-05 | SELL | 11,001 | $15 | $165K |
| OBrien Christopher Flint | Chief Medical Officer | 2013-07-12 | SELL | 5,000 | $14.5 | $72.5K |
| OBrien Christopher Flint | Chief Medical Officer | 2013-06-28 | SELL | 11,357 | $13.33 | $151.4K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2013-06-27 | SELL | 3,837 | $13 | $49.9K |
| Bozigian Haig P. | Chief Development Officer | 2013-06-27 | SELL | 8,000 | $13 | $104K |
| Bozigian Haig P. | Chief Development Officer | 2013-06-24 | SELL | 769 | $12.72 | $9.8K |
| OBrien Christopher Flint | Chief Medical Officer | 2013-06-21 | SELL | 36,143 | $12.43 | $449.3K |
| Bozigian Haig P. | Chief Development Officer | 2013-06-21 | SELL | 44,731 | $12.5 | $559.1K |
| Grigoriadis Dimitri E. | Chief Research Officer | 2013-06-21 | SELL | 46,837 | $12.51 | $585.9K |
| BVF PARTNERS L P/IL | 10% Owner | 2011-10-12 | BUY | 29,500 | $5.96 | $175.8K |
| BVF PARTNERS L P/IL | 10% Owner | 2011-10-11 | BUY | 73,900 | $5.6 | $413.8K |
| GORMAN KEVIN CHARLES | President and CEO | 2011-02-28 | SELL | 15,400 | $6.83 | $105.2K |
| Coughlin Timothy P | VP and CFO | 2011-02-28 | SELL | 12,320 | $6.83 | $84.1K |
| VALEUR JENSEN MARGARET E | EVP and General Counsel | 2011-02-28 | SELL | 12,320 | $6.83 | $84.1K |
| OBrien Christopher Flint | Sr. VP & Chief Medical Officer | 2011-02-28 | SELL | 12,320 | $6.83 | $84.1K |
| Grigoriadis Dimitri E. | Vice President, Research | 2011-02-28 | SELL | 12,320 | $6.82 | $84K |
| Bozigian Haig P. | Sr Vice President, Development | 2011-02-28 | SELL | 12,320 | $6.83 | $84.1K |
| BVF PARTNERS L P/IL | 10% Owner | 2010-04-12 | SELL | 198,000 | $2.78 | $550.4K |
| BVF PARTNERS L P/IL | 10% Owner | 2010-03-31 | SELL | 105,000 | $2.7 | $283.5K |
| BVF PARTNERS L P/IL | 10% Owner | 2010-03-29 | SELL | 413,100 | $2.7 | $1115.4K |
| BVF PARTNERS L P/IL | 10% Owner | 2010-03-24 | SELL | 189,000 | $2.76 | $521.6K |
| GORMAN KEVIN CHARLES | President and CEO | 2010-03-01 | SELL | 15,609 | $2.53 | $39.5K |
| Coughlin Timothy P | VP and CFO | 2010-03-01 | SELL | 12,650 | $2.53 | $32K |
| VALEUR JENSEN MARGARET E | EVP and General Counsel | 2010-03-01 | SELL | 12,490 | $2.53 | $31.6K |
| OBrien Christopher Flint | Sr. VP & Chief Medical Officer | 2010-03-01 | SELL | 13,490 | $2.53 | $34.1K |
| Grigoriadis Dimitri E. | Vice President, Research | 2010-03-01 | SELL | 13,955 | $2.53 | $35.3K |
| Bozigian Haig P. | Sr Vice President, Development | 2010-03-01 | SELL | 14,090 | $2.53 | $35.6K |
| VALEUR JENSEN MARGARET E | EVP and General Counsel | 2010-01-12 | SELL | 8,697 | $2.52 | $21.9K |
| Coughlin Timothy P | VP and CFO | 2010-01-12 | SELL | 8,697 | $2.52 | $21.9K |
| GORMAN KEVIN CHARLES | President and CEO | 2010-01-12 | SELL | 9,445 | $2.52 | $23.8K |
| OBrien Christopher Flint | Sr. VP & Chief Medical Officer | 2010-01-04 | SELL | 1,503 | $2.65 | $4K |
| Bozigian Haig P. | Sr Vice President, Development | 2010-01-04 | SELL | 751 | $2.64 | $2K |
| Grigoriadis Dimitri E. | Vice President, Research | 2010-01-04 | SELL | 1,503 | $2.67 | $4K |
| MITCHELL W THOMAS | Director | 2009-11-05 | BUY | 900 | $2.17 | $2K |
| OBrien Christopher Flint | Sr. VP & Chief Medical Officer | 2009-09-28 | SELL | 4,859 | $3.11 | $15.1K |
| Grigoriadis Dimitri E. | Vice President, Research | 2009-09-28 | SELL | 3,038 | $3.12 | $9.5K |
| Bozigian Haig P. | Sr Vice President, Development | 2009-09-28 | SELL | 3,642 | $3.11 | $11.3K |
| GORMAN KEVIN CHARLES | President and CEO | 2009-03-30 | SELL | 15,146 | $3.43 | $52K |
| VALEUR JENSEN MARGARET E | EVP and General Counsel | 2009-03-30 | SELL | 12,117 | $3.43 | $41.6K |
| Coughlin Timothy P | VP and CFO | 2009-03-30 | SELL | 12,117 | $3.43 | $41.6K |
| OBrien Christopher Flint | Sr. VP & Chief Medical Officer | 2009-03-30 | SELL | 12,151 | $3.43 | $41.7K |
| Grigoriadis Dimitri E. | Vice President, Research | 2009-03-30 | SELL | 12,606 | $3.43 | $43.2K |
| Bozigian Haig P. | Sr Vice President, Development | 2009-03-30 | SELL | 12,774 | $3.43 | $43.8K |
| BVF PARTNERS L P/IL | 2009-01-23 | BUY | 15,900 | $3.1 | $49.3K | |
| BVF PARTNERS L P/IL | 2009-01-21 | BUY | 100,200 | $3.08 | $308.6K | |
| BVF PARTNERS L P/IL | 2009-01-15 | BUY | 7,400 | $3.05 | $22.6K | |
| GORMAN KEVIN CHARLES | President & CEO, Director | 2009-01-13 | SELL | 9,195 | $3.37 | $31K |
| Coughlin Timothy P | VP and CFO | 2009-01-13 | SELL | 8,463 | $3.39 | $28.7K |
| VALEUR JENSEN MARGARET E | EVP and General Counsel | 2009-01-12 | SELL | 8,463 | $3.25 | $27.5K |
| OBrien Christopher Flint | Sr. VP & Chief Medical Officer | 2009-01-05 | SELL | 1,462 | $3.41 | $5K |
| Grigoriadis Dimitri E. | Vice President, Research | 2009-01-05 | SELL | 1,462 | $3.4 | $5K |
| Bozigian Haig P. | Sr Vice President, Development | 2009-01-05 | SELL | 733 | $3.4 | $2.5K |
| BVF PARTNERS L P/IL | 2008-12-30 | BUY | 10,600 | $2.8 | $29.7K | |
| BVF PARTNERS L P/IL | 2008-12-01 | BUY | 99,400 | $2.35 | $233.6K | |
| BVF PARTNERS L P/IL | 2008-11-24 | BUY | 54,400 | $2.45 | $133.3K | |
| BVF PARTNERS L P/IL | 2008-10-10 | BUY | 447,047 | $2.72 | $1216K | |
| OBrien Christopher Flint | Sr. VP & Chief Medical Officer | 2008-09-29 | SELL | 4,824 | $4.69 | $22.6K |
| Bozigian Haig P. | Sr Vice President, Development | 2008-09-29 | SELL | 3,618 | $4.7 | $17K |
| Grigoriadis Dimitri E. | Vice President, Research | 2008-09-29 | SELL | 3,017 | $4.71 | $14.2K |
| BVF PARTNERS L P/IL | 2008-07-08 | BUY | 119,100 | $4.24 | $505K | |
| BVF PARTNERS L P/IL | 2008-07-03 | BUY | 37,700 | $4.17 | $157.2K | |
| BVF PARTNERS L P/IL | 2008-05-28 | BUY | 27,100 | $4.72 | $127.9K | |
| BVF PARTNERS L P/IL | 2008-05-16 | BUY | 152,600 | $4.63 | $706.5K | |
| Grigoriadis Dimitri E. | Vice President, Research | 2008-05-13 | SELL | 6,485 | $5.05 | $32.7K |
| BVF PARTNERS L P/IL | 2008-03-20 | BUY | 43,600 | $5 | $218K | |
| BVF PARTNERS L P/IL | 2008-03-18 | BUY | 153,000 | $4.96 | $758.9K | |
| BVF PARTNERS L P/IL | 2008-03-13 | BUY | 23,900 | $4.92 | $117.6K | |
| BVF PARTNERS L P/IL | 2008-03-12 | BUY | 156,600 | $4.91 | $768.9K | |
| BVF PARTNERS L P/IL | 2008-03-10 | BUY | 329,600 | $4.92 | $1621.6K | |
| BVF PARTNERS L P/IL | 2008-03-06 | BUY | 86,700 | $5 | $433.5K | |
| BVF PARTNERS L P/IL | 2008-03-04 | BUY | 121,200 | $4.94 | $598.7K | |
| BVF PARTNERS L P/IL | 2008-02-29 | BUY | 70,400 | $5 | $352K | |
| BVF PARTNERS L P/IL | 2008-02-25 | BUY | 187,000 | $4.91 | $918.2K | |
| BVF PARTNERS L P/IL | 2008-02-21 | BUY | 106,000 | $4.7 | $498.2K | |
| RANIERI RICHARD J | Sr. VP, Human Resources | 2008-02-12 | SELL | 9,666 | $5.02 | $48.5K |
| VALEUR JENSEN MARGARET E | EVP and General Counsel | 2008-02-12 | SELL | 7,663 | $5.02 | $38.5K |
| Coughlin Timothy P | VP and CFO | 2008-02-12 | SELL | 7,857 | $5.02 | $39.4K |
| GORMAN KEVIN CHARLES | President & CEO | 2008-02-12 | SELL | 8,230 | $5.03 | $41.4K |
| Bozigian Haig P. | Sr Vice President, Development | 2008-02-05 | SELL | 722 | $5.31 | $3.8K |
| Grigoriadis Dimitri E. | Vice President, Research | 2008-02-05 | SELL | 1,206 | $5.31 | $6.4K |
| HAWRAN PAUL W | Executive VP and CFO | 2006-05-17 | SELL | 115,481 | $19.79 | $2285.4K |
| VALE WYLIE W | Director | 2006-03-03 | SELL | 10,000 | $70 | $700K |
| VALE WYLIE W | Director | 2005-12-21 | SELL | 10,000 | $65.02 | $650.2K |
| HAWRAN PAUL W | Executive VP and CFO | 2005-12-21 | SELL | 10,000 | $64.69 | $646.9K |
| GORMAN KEVIN CHARLES | Sr VP, Business Dev. | 2005-12-08 | SELL | 3,000 | $62.92 | $188.8K |
| LYONS GARY A | President and CEO | 2005-12-05 | SELL | 5,000 | $61.95 | $309.8K |
| POPS RICHARD F | Director | 2005-11-23 | SELL | 20,000 | $62.1 | $1242K |
| LYONS GARY A | President and CEO | 2005-11-22 | SELL | 5,000 | $61.78 | $308.9K |
| LYONS GARY A | President and CEO | 2005-11-18 | SELL | 5,000 | $59.7 | $298.5K |
| VALE WYLIE W | Director | 2005-11-18 | SELL | 10,000 | $60.02 | $600.2K |
| LYONS GARY A | President and CEO | 2005-11-03 | SELL | 10,000 | $56.28 | $562.8K |
| VALE WYLIE W | Director | 2005-11-02 | SELL | 5,021 | $55 | $276.2K |
| VALE WYLIE W | Director | 2005-11-01 | SELL | 4,979 | $55 | $273.8K |
| LYONS GARY A | President and CEO | 2005-10-28 | SELL | 10,000 | $51.5 | $515K |
| VALE WYLIE W | Director | 2005-09-07 | SELL | 10,000 | $50 | $500K |
| LYONS GARY A | President and CEO | 2005-09-07 | SELL | 10,000 | $49 | $490K |
| LYONS GARY A | President and CEO | 2005-08-18 | SELL | 5,000 | $46.76 | $233.8K |
| LYONS GARY A | President and CEO | 2005-06-15 | SELL | 5,000 | $39.7 | $198.5K |
| STEINMAN LAWRENCE | Director | 2005-03-02 | SELL | 4,000 | $41.1 | $164.4K |
| SHERWIN STEPHEN A | Director | 2004-09-22 | SELL | 2,500 | $49 | $122.5K |
| STEINMAN LAWRENCE | Director | 2004-09-15 | SELL | 2,000 | $50.25 | $100.5K |
| VALE WYLIE W | Director | 2004-09-01 | SELL | 10,000 | $50.03 | $500.3K |
| VALE WYLIE W | Director | 2004-08-27 | SELL | 10,000 | $50.07 | $500.7K |
| MITCHELL W THOMAS | Director | 2004-08-09 | BUY | 1,000 | $41.18 | $41.2K |
| LYONS GARY A | President and CEO | 2004-07-01 | SELL | 10,000 | $51.43 | $514.3K |
| VALE WYLIE W | Director | 2004-07-01 | SELL | 10,000 | $51.43 | $514.3K |
| VALE WYLIE W | Director | 2004-06-01 | SELL | 10,000 | $56.11 | $561.1K |
| LYONS GARY A | President and CEO | 2004-06-01 | SELL | 10,000 | $56.04 | $560.4K |
| LYONS GARY A | President and CEO | 2004-05-03 | SELL | 10,000 | $62.63 | $626.3K |
| VALE WYLIE W | Director | 2004-05-03 | SELL | 10,000 | $62.63 | $626.3K |
| LYONS GARY A | President and CEO | 2004-04-01 | SELL | 10,000 | $58.16 | $581.6K |
| VALE WYLIE W | Director | 2004-04-01 | SELL | 10,000 | $58.16 | $581.6K |
| VALE WYLIE W | Director | 2004-03-02 | SELL | 10,000 | $55.05 | $550.5K |
| LYONS GARY A | President and CEO | 2004-03-01 | SELL | 10,000 | $54.15 | $541.5K |
| HAWRAN PAUL W | Executive VP and CFO | 2004-02-11 | SELL | 10,000 | $56.68 | $566.8K |
| GORMAN KEVIN CHARLES | Vice President Business Dev. | 2004-02-10 | SELL | 6,000 | $57.35 | $344.1K |
| VALE WYLIE W | Director | 2004-02-05 | SELL | 20,000 | $54.73 | $1094.6K |
| LYONS GARY A | President and CEO | 2004-02-03 | SELL | 10,000 | $56.62 | $566.2K |
| SAUNDERS JOHN | Vice President Research (Chem) | 2003-12-18 | SELL | 6,000 | $54.61 | $327.7K |
| CONLON PAUL J | Vice President Research (Biol) | 2003-12-16 | SELL | 5,000 | $53.6 | $268K |
| VALE WYLIE W | Director | 2003-12-12 | SELL | 9,703 | $55.06 | $534.2K |
| SAUNDERS JOHN | Vice President Research (Chem) | 2003-12-11 | SELL | 5,000 | $55.21 | $276.1K |
| LYONS GARY A | President and CEO | 2003-12-11 | SELL | 10,000 | $54.98 | $549.8K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked